Dyslipidemia management among HIV-infected patients treated with protease inhibitors

被引：0
|
作者：
Darkow, T
Ventura, EP
Wu, Y
机构：
[1] Prescript Solut, Costa Mesa, CA USA
[2] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)63988-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：254 / 254
页数：1
相关论文
共 50 条
  • [1] Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors
    Périard, D
    Telenti, A
    Sudre, P
    Cheseaux, JJ
    Halfon, P
    Reymond, MJ
    Marcovina, SM
    Glauser, MP
    Nicod, P
    Darioli, R
    Mooser, V
    [J]. CIRCULATION, 1999, 100 (07) : 700 - 705
  • [2] Metabolic disorders among HIV-infected patients treated with protease inhibitors: A review
    Graham, NM
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 : S4 - S11
  • [3] Dyslipidemia among HIV-infected patients
    Wiwanitkit, Somsri
    Wiwanitkit, Viroj
    [J]. ANNALS OF AFRICAN MEDICINE, 2014, 13 (03)
  • [4] Coagulation studies in HIV-infected patients treated with protease inhibitors
    Pulik, M
    Jary, L
    Genet, P
    Lebret-Lerolle, D
    Fourcade, C
    Lionnet, F
    Touahri, T
    Louvel, D
    Jondeau, K
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 134 - 134
  • [5] Management of dyslipidemia in HIV-infected patients
    Malvestutto, Carlos D.
    Aberg, Judith A.
    [J]. CLINICAL LIPIDOLOGY, 2011, 6 (04) : 447 - 462
  • [6] Dyslipidemia and lipid management in HIV-infected patients
    Lo, Janet
    [J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (02) : 144 - 147
  • [7] Subclinical carotid atherosclerosis in HIV-infected patients treated with nevirapine or protease inhibitors
    Calza, L.
    Verucchi, G.
    Colangeli, V.
    Manfredi, R.
    Piergentili, B.
    Cascavilla, A.
    Serra, C.
    Viale, P.
    [J]. INFECTION, 2010, 38 : 72 - 72
  • [8] HIV-infected patients, quality of life and protease inhibitors
    González, IM
    Ordóñez, MAG
    Simonet, MVS
    Fernández, CJ
    [J]. MEDICINA CLINICA, 2000, 114 (05): : 196 - 196
  • [9] Metabolic abnormalities and cardiovascular risk in HIV-infected cohort of patients treated with protease inhibitors
    Flisiak, R.
    Wiercinska-Drapalo, A.
    Bociaga-Jasik, M.
    Baralkiewicz, G.
    Grzeszczuk, A.
    Olczak, A.
    Grabczewska, E.
    Parczewski, M.
    Jablonowska, E.
    Dabowska, M.
    Kozlowska, J.
    Mikula, T.
    Witor, A.
    Gasiorowski, J.
    Latarska-Smuga, D.
    Scibiorski, C.
    Knyszk, B.
    [J]. HIV & AIDS REVIEW, 2015, 14 (01): : 22 - 27
  • [10] Whole body leucine flux in HIV-infected patients treated with or without protease inhibitors
    Prod'homme, M
    Rochon, C
    Balage, M
    Laurichesse, H
    Tauveron, I
    Champredon, C
    Thieblot, P
    Beytout, J
    Grizard, J
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 290 (04): : E685 - E693
12345